To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03601078
Title An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma Having Progressed Within One Year of Initial Treatment (KarMMa-2)
Acronym KarMMa-2
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
Mayo Clinic in Arizona - Scottsdale Scottsdale Arizona 85259 United States Details
University Of California San Francisco Medical Center San Francisco California 94143 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Emory University School of Medicine Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Boston Massachusetts 02117 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215-5450 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
University Of Nebraska Omaha Nebraska 68198-7680 United States Details
John Theurer Cancer Center at Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Mt Sinai Medical Center - NY New York New York 10029 United States Details
Columbia University Medical Center/New York-Presbyterian Hospital New York New York 10032 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
Tennessee Oncology PLLC Nashville Tennessee 37203 United States Details
University Of Texas Southwestern Medical Center Dallas Texas 75390 United States Details
MD Anderson Cancer Center The University of Texas Houston Texas 77030 United States Details
Swedish Cancer Inst Seattle Washington 98104 United States Details
Froedtert Hospital BMT Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
Local Institution - 404 Poitiers 86021 France Details
Local Institution - 506 Hamburg 20246 Germany Details
Local Institution - 505 Würzburg 97080 Germany Details
Local Institution - 603 Bologna 40138 Italy Details
Clinica Universidad de Navarra Pamplona 31008 Spain Details
Local Institution - 704 Salamanca 37007 Spain Details
Kings College Hospital NHS Foundation Trust London SE5 9RS United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field